REGN

Regeneron Pharmaceuticals News

Best deals to access real time data!
Big Cap Pro
Monthly Subscription
for only
$52.04
Small Cap Basic
Monthly Subscription
for only
$33.03
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$67.09
VAT not included
Company Name Stock Ticker Symbol Market Type
Regeneron Pharmaceuticals Inc REGN NASDAQ Common Stock
  Price Change Change Percent Stock Price Last Traded
-0.55 -0.11% 516.62 20:00:00
Open Price Low Price High Price Close Price Prev Close
519.38 512.33 520.6813 516.62 517.17
more quote information »

Recent News

Date Time Source Heading
5/12/202113:30PRNUSPositive Phase 3 Libtayo® (cemiplimab) Results in Advanced..
5/10/202106:52SEEKCheckmate Pharma teams up with Regeneron to evaluate..
5/06/202107:23EDGARQuarterly Report (10-q)
5/06/202107:15SEEKRegeneron Pharma off to a strong start in 2021 with..
5/06/202107:14DJNRegeneron 1Q Revenue Increases, With Gain From Covid-19..
5/06/202106:31SEEKRegeneron Pharmaceuticals EPS beats by $1.19, misses on..
5/06/202106:30PRNUSRegeneron Reports First Quarter 2021 Financial and Operating..
5/05/202112:54SEEKRegeneron Pharmaceuticals Q1 2021 Earnings Preview
5/03/202108:00PRNUSATS 2021 Breaking News Session to Feature Pivotal Data on..
4/23/202116:17EDGARAdditional Proxy Soliciting Materials (definitive) (defa14a)
4/23/202116:12EDGARProxy Statement (definitive) (def 14a)
4/23/202116:05PRNUSRegeneron Announces Investor Conference Presentations
4/23/202109:59PRNUSNew Dupixent® (dupilumab) Analyses at Two Upcoming..
4/15/202113:39SEEKMerck hurt by another setback in its battle against COVID-19
4/12/202107:16TRMNRegeneron’s REGEN-COV Shown To Reduce COVID-19 Progression..
4/12/202104:48DJNCovid-19 Drug Prevents Symptomatic Disease in Study,..
4/12/202102:50SEEKRegeneron/Roche's antibody cocktail reduces risk of COVID-19..
4/12/202101:52DJNRoche's Phase 3 Trial of Casirivimab, Imdevimab Shows Cut..
4/12/202101:15PRNUSPhase 3 Treatment Trial in Recently Infected Asymptomatic..
4/12/202101:00PRNUSPhase 3 Prevention Trial Showed 81% Reduced Risk of..
4/09/202109:20DJNRegeneron Pharma Covid-19 Treatment Recommended by National..
4/09/202108:15PRNUSNIH COVID-19 Treatment Guidelines Strongly Recommend Use of..
4/06/202116:05PRNUSRegeneron to Report First Quarter 2021 Financial and..
3/31/202103:58SEEKRegeneron's Eylea reduces vision loss by 68% after two years..
3/30/202119:04PRNUSNIH-sponsored Trial Finds EYLEA® (aflibercept) Injection..
3/23/202102:47SEEKRegeneron's COVID-19 antibody reduces hospitalization, death..
3/23/202102:29DJNRegeneron Covid-19 Antibody Drug Reduced Risk of..
3/23/202102:00PRNUSPhase 3 Trial Shows REGEN-COV™ (casirivimab with imdevimab)..
3/19/202110:43TRMNKiniksa Wins FDA Nod For ARCALYST Injection therapy; Shares..
3/17/202120:57PRNUSTeen Scientists Win $1.8 Million at Virtual Regeneron..
3/15/202106:41DJNRegeneron, Sanofi: Positive Libtayo Phase 3 Study in..
3/15/202102:00PRNUSPhase 3 Trial of Libtayo® (cemiplimab) Monotherapy in..
3/04/202106:26DJNRegeneron, Sanofi: FDA to Review Dupixent for Asthma Attacks..
3/04/202100:59PRNUSFDA Accepts Dupixent® (dupilumab) for Review in Children..
3/03/202117:07SEEKRegeneron and Kiniksa sign commercial supply agreement for..
3/01/202102:52TRMNRegeneron Antibody Therapy For Cat-Allergic Asthma Patients..
2/27/202121:04SEEKRegeneron’s antibody cocktail shows promise in cat-allergic..
2/27/202118:25PRNUSRegeneron Announces Positive Phase 2 Data Evaluating Fel d 1..
2/26/202108:05DJNEuropean Medicines Agency Supports Roche's Covid-19 Antibody..
2/26/202106:46PRNUSEMA Issues Advice on Regeneron's Antibody Cocktail..
2/25/202107:00PRNUSIndependent Data Monitoring Committee Finds Clear Efficacy..
2/24/202108:03SEEKDecibel Therapeutics posts hearing loss gene therapy..
2/22/202113:45DJNRegeneron, Sanofi Gets FDA OK of Libtayo in Advanced..
2/22/202113:00PRNUSFDA Approves Libtayo® (cemiplimab-rwlc) Monotherapy for..
2/16/202113:01EDGARSchedule 13g
2/12/202116:15PRNUSRegeneron Announces Investor Conference Presentations
2/12/202103:50TRMNRegeneron Wins FDA Nod For Evkeeza Antibody Therapy; Street..
2/12/202101:00PRNUSThe Lancet Publishes Libtayo® (cemiplimab) Data Showing..
2/11/202117:04PRNUSU.S. Federal Circuit Court of Appeals Rules in Favor of..
2/11/202115:01DJNRegeneron: FDA Approves Evkeeza in Rare Form of High..
See more news about this stock »


Your Recent History
NASDAQ
REGN
Regeneron ..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.